SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)

NCT05718232 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: Lenvatinib
PROCEDURE: TACE
RADIATION: SBRT

Sponsor

Sun Yat-sen University